Figure 3From: Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials Distribution of HER2 , TOP2A and CEP17 copies (A, B and C). Red line represents 6 gene copies (for A and B) and 3 copies for C.Back to article page